Jefferies Group acquired 10.3M Taysha Gene Therapies shares worth $33.6M. That's 0.57% of their equity portfolio (42nd largest holding). The investor owns 8.16% of the outstanding Taysha Gene Therapies stock. The first Taysha Gene Therapies trade was made in Q1 2024. Since then Jefferies Group bought shares three more times and sold shares on two occasions. The stake costed the investor $22.3M, netting the investor a gain of 51% so far.
Vanguard Group Inc. grew its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) by 36.6% during the second quarter, according to its most recent...
Legal & General Group Plc grew its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) by 310.2% in the 2nd quarter, according to its most recent...